General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-25 | 2024-03 | 0.64 | 0.66 | 0.02 | 3.13% |
2024-02-06 | 2023-12 | 0.64 | 0.64 | N/A | N/A |
2023-10-25 | 2023-09 | 0.59 | 0.59 | N/A | N/A |
2023-07-26 | 2023-06 | 0.65 | 0.66 | 0.01 | 1.54% |
2023-04-26 | 2023-03 | 0.61 | 0.62 | 0.01 | 1.64% |
2023-01-31 | 2022-12 | 0.61 | 0.64 | 0.03 | 4.92% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-15 | Leerink Partners | Upgrade | Market Perform | |
2023-10-01 | Citigroup | Upgrade | Buy | Buy |
2023-09-25 | Oppenheimer | Upgrade | Perform | Outperform |
2023-09-07 | Piper Sandler | Upgrade | Neutral | Neutral |
2023-08-16 | RBC Capital | Upgrade | Outperform | Outperform |
2023-07-31 | RBC Capital | Upgrade | Outperform | Outperform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-05-02 | BOBO DONALD E JR | Officer | 215.44K | Conversion of Exercise of derivative security |
2024-05-02 | CHOPRA DAVEEN | Officer | 24.85K | Conversion of Exercise of derivative security |
2024-02-22 | GALLAHUE KIERAN T. | Director | 70.92K | Stock Gift |
2024-05-02 | LEMERCIER JEAN-LUC M | Officer | 177.71K | Conversion of Exercise of derivative security |
2024-04-08 | LIPPIS DANIEL J | Officer | 17.49K | Sale |
2024-05-01 | MUSSALLEM MICHAEL A | Director | 4.04M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 51.31M | 4.84B | 8.44% |
2023-06-29 | Blackrock Inc. | 50.81M | 4.79B | 8.36% |
2023-06-29 | State Street Corporation | 27.05M | 2.55B | 4.45% |
2023-06-29 | Capital International Investors | 27.02M | 2.55B | 4.44% |
2023-06-29 | Alliancebernstein L.P. | 20.51M | 1.93B | 3.37% |
2023-06-29 | Bank Of New York Mellon Corporation | 17.71M | 1.67B | 2.91% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 18.92M | 1.78B | 3.11% |
2023-06-29 | Vanguard 500 Index Fund | 14.43M | 1.36B | 2.37% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 9.39M | 770.32M | 1.54% |
2023-05-30 | Fidelity 500 Index Fund | 6.92M | 582.74M | 1.14% |
2023-08-30 | SPDR S&P 500 ETF Trust | 6.68M | 510.77M | 1.10% |
2023-06-29 | Growth Fund Of America Inc | 6.63M | 624.95M | 1.09% |
Split | Date |
---|---|
3 : 1 | 2020-06-01 |
2 : 1 | 2015-12-14 |
2 : 1 | 2010-05-28 |
1 : 1 | 2010-05-27 |
All thanks to Mrs. Karen J Adams that helped me achieve my dreams through her trading program, I made over $30,000 in duration of 4 days she's so excellent and amazing. Visit her on TELEGRAM ᏦᎪᎡᎬΝ Ꭻ ᎪᎠᎪᎷՏ or WhatsApp +❶❽❶❷❷❼⓿❻❽⓿❼
How many knew that Ocugen had a partnership which contractually GUARANTEES them revenues from Covid19 Antibody Testing?
(re: page 22 of annual report):
https://www.sec.gov/Archives/edgar/data/1372299/000110465920053502/tm2017927-1_10ka.htm
Collaboration with Advaite, Inc.
In April 2020, the Company entered into an agreement with Advaite, Inc., (Advaite) to provide certain support services for Advaite's development of a diagnostic test kit that is designed to detect antibodies to COVID-19. ...{Ocugen}... will receive tiered royalty payments based on cumulative net sales of the test kit.
The projected market for Covid diagnostic testing is $61B AND GROWING!
MORE IMPORTANTLY Advaite is NOW MOVING on Covid Antibody Testing!
https://www.linkedin.com/mwlite/company/advaite
*
The BEAUTY here:
NOBODY KNOWS Ocugen will be collecting potentially BILLION$ in COVID DIAGNOSTICS revenue! They NEVER did a PRESS RELEASE!